Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | PIP4K2A | P48426 | 1/20 | 0.41 |
| ▸ | PIP4K2C | Q8TBX8 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | LOX | P28300 | 1/20 | 0.39 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.38 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.38 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.38 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.38 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30700822 | 1.00 | PTGS2 (0.46) | PTGS2LMNAPIP4K2APIP4K2CRECQL | |
| SCHEMBL15390838 | 0.84 | PTGS2 (0.38) | PTGS2PIP4K2APIP4K2CRECQLLOX | |
| SCHEMBL724036 | 0.83 | TDP1 (0.46) | PTGS2RECQLLOXLOXL3LOXL2 | |
| SCHEMBL3993358 | 0.81 | PTGS2 (0.54) | PTGS2PIP4K2APIP4K2CPTGS1 | |
| SCHEMBL4001581 | 0.81 | NR1H2 (0.49) | PTGS2PIP4K2APIP4K2CLOXL2PTGS1 | |
| SCHEMBL29131027 | 0.80 | PSIP1 (0.42) | RECQLLOXLOXL3LOXL2NR1H2 | |
| SCHEMBL4012759 | 0.79 | NR1H2 (0.48) | PTGS2PIP4K2APIP4K2CLOXL2PTGS1 | |
| SCHEMBL2241153 | 0.79 | CA1 (0.47) | PTGS2LMNARECQLLOXLOXL3 | |
| SCHEMBL15392663 | 0.79 | CA12 (0.50) | LMNAALDH1A1 | |
| Hydrochloric Acid SCHEMBL28177603 | 0.78 | RECQL (0.42) | LMNARECQLLOXLOXL3LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109688816-A | Active compound combinations and method for protecting plant propagation material | 拜耳作物科学股份公司 | 2019-04-26 | — | — | CN | claimed |
| CN-106478494-B | The production method of the chloro- 4- methanesulfonylpyridine of 2,3,5,6- tetra- | 南通海迪新材料有限公司 | 2019-03-15 | — | — | CN | claimed |
| CN-108794389-A | The preparation method of tetra- chloro- 4- methanesulfonylpyridines of 2,3,5,6- | 利尔化学股份有限公司 | 2018-11-13 | — | — | CN | claimed |
| CN-108282996-A | Microbial compositions for use in combination with soil insecticides to promote plant growth | FMC有限公司 | 2018-07-13 | — | — | CN | claimed |
| CN-107820392-A | Bacillus amyloliquefaciens RTI472 compositions and for beneficial to plant growth and treatment plant disease method | FMC有限公司 | 2018-03-20 | — | — | CN | claimed |
| CN-104204057-B | Thiabendazole and the stable compositions containing iodine antifungal | 朗盛德国有限责任公司 | 2016-10-05 | — | — | CN | claimed |
| CN-103607881-B | Method for cultivating sugarcane | BASF SE (DE) | 2016-01-13 | — | — | CN | claimed |
| CN-102448295-B | The method of control harmful fungoid | BASF SE (DE) | 2015-11-25 | — | — | CN | claimed |
| CN-102448291-B | Method for reducing sun damage of plants | BASF SE | 2015-05-27 | — | — | CN | claimed |
| CN-102802416-A | Fungicidal mixtures | BASF SE | 2012-11-28 | — | — | CN | claimed |
| CN-102595903-A | Fungicidal mixtures | BASF SE | 2012-07-18 | — | — | CN | claimed |
| CN-102458124-A | Fungicidal mixtures | BASF SE | 2012-05-16 | — | — | CN | claimed |
| EP-3870577-B1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV HEALTHCARE UK NO 5 LTD (GB) | 2025-03-19 | — | — | EP | disclosed |
| US-20230109662-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV Healthcare UK (No.5) Limited (GB) | 2023-04-06 | — | — | US | disclosed |
| US-11541055-B2 | Inhibitors of human immunodeficiency virus replication | VIIV Healthcare UK (No.5) Limited (GB) | 2023-01-03 | — | — | US | disclosed |
| CN-113195475-A | Inhibitors of human immunodeficiency virus replication | VIIV保健英国第五有限公司 | 2021-07-30 | — | — | CN | disclosed |
| EP-0719260-A1 | BUTENOL-TRIAZOLYL DERIVATIVES, THEIR MANUFACTURE AND USE AS MICROBICIDES | BAYER AG (DE) | 1996-07-03 | — | — | EP | disclosed |
| EP-0702670-A1 | IODOPROPARGYL CARBAMATES AND THEIR USE AS BIOCIDES IN THE PROTECTION OF PLANTS AND MATERIALS | BAYER AG (DE) | 1996-03-27 | — | — | EP | disclosed |
| WO-1995022530-A1 | N-PYRAZOLYL ANILINES AND N-PYRAZOLYL AMINOPYRIDINES AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1995-08-24 | — | — | WO | disclosed |
| WO-1995007896-A1 | BUTENOL-TRIAZOLYL DERIVATIVES, THEIR MANUFACTURE AND USE AS MICROBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1995-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11541055-B2 | Inhibitors of human immunodeficiency virus replication | EIF2AK2, POLR2E, POLR2H | PTGS2 2899/4885LMNA 3667/4885PIP4K2A 923/4885 |
| US-20230109662-A1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | EIF2AK2, POLR2E, POLR2H | PTGS2 2899/4885LMNA 3667/4885PIP4K2A 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.